Supramolecular protein engineering: design of zinc-stapled insulin hexamers as a long acting depot.Phillips, N.B., Wan, Z.L., Whittaker, L., Hu, S.Q., Huang, K., Hua, Q.X., Whittaker, J., Ismail-Beigi, F., Weiss, M.A.
(2010) J Biol Chem 285: 11755-11759
- PubMed: 20181952
- DOI: 10.1074/jbc.C110.105825
- Primary Citation of Related Structures:
- PubMed Abstract:
- Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.
Wan, Z.L., Xu, B., Chu, Y.C., Li, B., Nakagawa, S.H., Qu, Y., Hu, S.Q., Katsoyannis, P.G., Weiss, M.A.
(2004) Biochemistry 43: 16119
- The structure of 2zn pig insulin crystal at 1.5 A resolution
Baker, E.N., Blundell, T.L., Cutfield, J.F., Cutfield, S.M., Dodson, E.J., Dodson, G.G., Hodgkin, D., Isaacs, N.W., Reynolds, C.D.
(1988) Philos Trans R Soc London,ser B 319: 369
- Structure of insulin in 4-zinc insulin
Bentley, G., Dodson, E., Dodson, G., Hodgkin, D., Mercola, D.
(1976) Nature 261: 166
- Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer
Derewenda, U., Derewenda, Z., Dodson, E., Dodson, G., Reynold, C., Smith, G., Sparks, C., Swenson, D.
(1989) Nature 338: 594
Bottom-up control of supramolecular protein assembly can provide a therapeutic nanobiotechnology. We demonstrate that the pharmacological properties of insulin can be enhanced by design of "zinc staples" between hexamers. Paired (i, i+4) His substitutions were introduced at an alpha-helical surface ...
Bottom-up control of supramolecular protein assembly can provide a therapeutic nanobiotechnology. We demonstrate that the pharmacological properties of insulin can be enhanced by design of "zinc staples" between hexamers. Paired (i, i+4) His substitutions were introduced at an alpha-helical surface. The crystal structure contains both classical axial zinc ions and novel zinc ions at hexamer-hexamer interfaces. Although soluble at pH 4, the combined electrostatic effects of the substitutions and bridging zinc ions cause isoelectric precipitation at neutral pH. Following subcutaneous injection in a diabetic rat, the analog effected glycemic control with a time course similar to that of long acting formulation Lantus. Relative to Lantus, however, the analog discriminates at least 30-fold more stringently between the insulin receptor and mitogenic insulin-like growth factor receptor. Because aberrant mitogenic signaling may be associated with elevated cancer risk, such enhanced specificity may improve safety. Zinc stapling provides a general strategy to modify the pharmacokinetic and biological properties of a subcutaneous protein depot.
Department of Biochemistry, Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.